Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study.
Depressive symptoms were rated during a double-blind placebo-controlled trial of nadolol for chronic aggression. Depressive symptoms were not significantly different in nadolol and placebo groups during any phase of the drug trial.
Sorgi
P
P
Worcester State Hospital, Massachusetts.
Ratey
J
J
Knoedler
D
D
Arnold
W
W
Cole
L
L
D000328:Adult; D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D003866:Depressive Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D009248:Nadolol / Q000008:administration & dosage / Q000009:adverse effects*; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales
D009248:Nadolol